Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Elaine B. Hoffman"'
Autor:
Doris L. Kwan, Behrooz Behbod, Thomas A.E. Platts-Mills, Soma Datta, Jimmy A. Kamel, Elaine B. Hoffman, Diane R. Gold, Brent A. Coull, Ginger L. Chew, Harriet A. Burge, Tara Webb, Joel Schwartz, James A. Scott, Joanne E. Sordillo, Michael L. Muilenberg
Publikováno v:
Clinical & Experimental Allergy. 45:154-163
Infancy is a developmental stage with heightened susceptibility to environmental influences on the risk of chronic childhood disease. Few birth cohort studies have detailed measures of fungal diversity data in infants' bedrooms, limiting the potentia
Autor:
Wanda Phipatanakul, Jonathan M. Gaffin, Elaine B. Hoffman, Benjamin A. Raby, Carter R. Petty, Diane R. Gold, Andrea A. Baccarelli
Publikováno v:
Clinical & Experimental Allergy. 44:681-689
SummaryBackground Genetic variation in the β-2 adrenergic receptor gene (ADRB2) has been implicated in asthma severity and control with conflicting results. Epigenetic variation in the ADRB2 may play an important role in asthma phenotype. Objective
Autor:
Marc S. Sabatine, Angela F. Ren, Stephanie E. Chiuve, David A. Morrow, Sotirios Tsimikas, Christopher P. Cannon, Frank M. Sacks, Michael J. Domanski, Elaine B. Hoffman, Kiyohito Arai, Michelle L. O'Donoghue, Scott D. Solomon, Nihar R. Desai, Sarah Sloan
Publikováno v:
Journal of the American College of Cardiology. 63(6):520-527
ObjectivesThe purpose of this study was to assess the prognostic utility of lipoprotein(a) [Lp(a)] in individuals with coronary artery disease (CAD).BackgroundData regarding an association between Lp(a) and cardiovascular (CV) risk in secondary preve
Autor:
Jing Zhou, Payal Kohli, Elaine B. Hoffman, Nihar R. Desai, Thomas Liu, Ransi Somaratne, Marc S. Sabatine, Robert P. Giugliano, Scott M. Wasserman, Rob Scott
Publikováno v:
Journal of the American College of Cardiology. 63:430-433
Objectives This study sought to define the ability of AMG 145, a monoclonal antibody directed against proprotein convertase subtilisin kexin type 9 (PCSK9), to enable subjects at high risk for major adverse cardiovascular events to achieve National C
Autor:
Ph. Gabriel Steg, Bernard J. Gersh, Mark J. Alberts, Elaine B. Hoffman, Christian T. Ruff, Shinya Goto, E. Magnus Ohman, Gregory Y.H. Lip, Deepak L. Bhatt, Kim A. Eagle
Publikováno v:
International Journal of Cardiology. 170:413-418
Patients with atrial fibrillation (AF) are at increased risk of thromboembolic events. The long-term prognostic implications of AF in patients with atherothrombosis are unknown.We compared 4-year CV outcomes in patients with and without a history of
Autor:
Sidney C. Smith, Fatima Rodriguez, Kim A. Eagle, Ph. Gabriel Steg, Deepak L. Bhatt, Dharam J. Kumbhani, E. Magnus Ohman, Amarachi A. Umez-Eronini, Elaine B. Hoffman, Christopher P. Cannon, Shinya Goto
Publikováno v:
Clinical Cardiology. 36:721-727
Background: Despite overall improvements in cardiovascular-disease therapies and outcomes, medication nonadherence remains an important barrier to effective secondary prevention of atherothrombotic disease. Hypothesis: Long-term medication adherence
Association of Low to Moderate Levels of Arsenic Exposure With Risk of Type 2 Diabetes in Bangladesh
Autor:
Wen Chi Pan, Golam Mahiuddin, Golam Mostofa, Quan Lu, David C. Christiani, Mahmuder Rahman, Quazi Quamruzzaman, Wei Jie Seow, Molly L. Kile, Elaine B. Hoffman
Publikováno v:
American Journal of Epidemiology. 178:1563-1570
Chronic exposure to high levels of arsenic in drinking water is associated with increased risk of type 2 diabetes mellitus (T2DM), but the association between lower levels of arsenic and T2DM is more controversial. Therefore, this study evaluated the
Autor:
Ransi Somaratne, Michelle L. O'Donoghue, Elaine B. Hoffman, Jing Zhou, Nihar R. Desai, Marc S. Sabatine, Scott M. Wasserman, Robert P. Giugliano, Fannie Huang, Rob Scott, Payal Kohli, William J. Rogers
Publikováno v:
Circulation. 128:962-969
Background— Lipoprotein(a) [Lp(a)] is an emerging risk factor for cardiovascular disease. Currently, there are few available therapies to lower Lp(a). We sought to evaluate the impact of AMG145, a monoclonal antibody against proprotein convertase s
Autor:
Alawi A. Alsheikh-Ali, E. Magnus Ohman, Avi Porath, Ramón Corbalán, Elaine B. Hoffman, Amarachi A. Umez-Eronini, Shinya Goto, Peter W.F. Wilson, Benjamin M. Scirica, Deepak L. Bhatt, Jacob A. Udell, Ph. Gabriel Steg, Kim A. Eagle
Publikováno v:
European Journal of Preventive Cardiology. 21:1531-1540
The incidence of metabolic syndrome (MetS), diabetes mellitus (DM), and their coexistence is increasing but whether MetS increases cardiovascular risk beyond component risk factors is controversial.We compared the risk of cardiovascular death, myocar